(Q73705341)
Statements
Effects of olomoucine, a selective inhibitor of cyclin-dependent kinases, on cell cycle progression in human cancer cell lines (English)
C Buquet-Fagot
F Lallemand
M N Montagne
scientific article published on 01 July 1997